Publications

Filters: Biosimilar medicines
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

2 November 2020

External Resource

Read more

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Read More

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Read More

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Read More

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Read More

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Read More

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Read More

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

Read More

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]
Medicines For Europe